Anixa Biosciences
ANIX
66 hedge funds and large institutions have $17.9M invested in Anixa Biosciences in 2025 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 17 increasing their positions, 7 reducing their positions, and 7 closing their positions.
400% more call options, than puts
Call options by funds: $85K | Put options by funds: $17K
143% more repeat investments, than reductions
Existing positions increased: 17 | Existing positions reduced: 7
14% more first-time investments, than exits
New positions opened: 8 | Existing positions closed: 7
1% more capital invested
Capital invested by funds: $17.6M → $17.9M (+$224K)
0% more funds holding
Funds holding: 66 → 66 (0)
0.16% less ownership
Funds ownership: 16.61% → 16.45% (-0.16%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$201K |
| 2 |
Marshall Wace
London,
United Kingdom
|
+$161K |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$93.1K |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$79.3K |
| 5 |
Acadian Asset Management
Boston,
Massachusetts
|
+$65.7K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Jane Street
New York
|
-$132K |
| 2 |
UBS Group
Zurich,
Switzerland
|
-$97.5K |
| 3 |
BFS
Bradley Foster & Sargent
Hartford,
Connecticut
|
-$66.9K |
| 4 |
LNWTC
Laird Norton Wetherby Trust Company
Seattle,
Washington
|
-$63.3K |
| 5 |
Focus Partners Wealth
Boston,
Massachusetts
|
-$60.2K |
ANIX Hedge Fund Activity: Q3 2025 in Review
66 of the 7,640 institutional investors tracked by Wall St. Rank reported a position in Anixa Biosciences (ANIX) for Q3 2025, worth a combined $17.9M — up 1.3% from $17.6M a quarter earlier.
Buyers outnumbered sellers: 8 funds opened new ANIX positions and 7 closed out — a net gain of 1 holder — while 17 added to existing stakes and 7 trimmed.
The largest buyer was Susquehanna International Group, adding an estimated $201K. The largest seller was Jane Street, exiting entirely with an estimated $132K sold.
- 66 institutional investors held Anixa Biosciences (ANIX) as of Q3 2025, unchanged from Q2 2025.
- Funds reported $17.9M of Anixa Biosciences stock for Q3 2025, up 1.3% quarter-over-quarter.
- 8 funds opened new Anixa Biosciences positions in Q3 2025 and 7 closed out, a net change of +1 holder.
- The largest Anixa Biosciences buyer in Q3 2025 was Susquehanna International Group, an estimated $201K added.
- The largest Anixa Biosciences seller in Q3 2025 was Jane Street, an estimated $132K sold.
Based on aggregated 13F filings for Q3 2025.